These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 31405746

  • 1. Experience in Liver Transplantation Due to Primary Sclerosing Cholangitis: A Single Center Experience.
    Emek E, Serin A, Sahin T, Yazici P, Yuzer Y, Tokat Y, Bozkurt B.
    Transplant Proc; 2019 Sep; 51(7):2439-2441. PubMed ID: 31405746
    [Abstract] [Full Text] [Related]

  • 2. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience.
    Goss JA, Shackleton CR, Farmer DG, Arnaout WS, Seu P, Markowitz JS, Martin P, Stribling RJ, Goldstein LI, Busuttil RW.
    Ann Surg; 1997 May; 225(5):472-81; discussion 481-3. PubMed ID: 9193175
    [Abstract] [Full Text] [Related]

  • 3. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis.
    Vera A, Gunson BK, Ussatoff V, Nightingale P, Candinas D, Radley S, Mayer A, Buckels JA, McMaster P, Neuberger J, Mirza DF.
    Transplantation; 2003 Jun 27; 75(12):1983-8. PubMed ID: 12829898
    [Abstract] [Full Text] [Related]

  • 4. Liver transplantation for primary sclerosing cholangitis: a long-term clinicopathologic study.
    Khettry U, Keaveny A, Goldar-Najafi A, Lewis WD, Pomfret EA, Pomposelli JJ, Jenkins RL, Gordon FD.
    Hum Pathol; 2003 Nov 27; 34(11):1127-36. PubMed ID: 14652814
    [Abstract] [Full Text] [Related]

  • 5. Activity of Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis Predicts Poorer Clinical Outcomes.
    Peverelle M, Paleri S, Hughes J, De Cruz P, Gow PJ.
    Inflamm Bowel Dis; 2020 Nov 19; 26(12):1901-1908. PubMed ID: 31944235
    [Abstract] [Full Text] [Related]

  • 6. Biliary strictures and recurrence after liver transplantation for primary sclerosing cholangitis: A retrospective multicenter analysis.
    Hildebrand T, Pannicke N, Dechene A, Gotthardt DN, Kirchner G, Reiter FP, Sterneck M, Herzer K, Lenzen H, Rupp C, Barg-Hock H, de Leuw P, Teufel A, Zimmer V, Lammert F, Sarrazin C, Spengler U, Rust C, Manns MP, Strassburg CP, Schramm C, Weismüller TJ, German PSC Study Group.
    Liver Transpl; 2016 Jan 19; 22(1):42-52. PubMed ID: 26438008
    [Abstract] [Full Text] [Related]

  • 7. The impact of inflammatory bowel disease post-liver transplantation for primary sclerosing cholangitis.
    Joshi D, Bjarnason I, Belgaumkar A, O'Grady J, Suddle A, Heneghan MA, Aluvihare V, Rela M, Heaton N, Agarwal K.
    Liver Int; 2013 Jan 19; 33(1):53-61. PubMed ID: 22103794
    [Abstract] [Full Text] [Related]

  • 8. Characteristics and impact of sex in a cohort of patients with primary sclerosing cholangitis: Experience of a transplant center in the Mediterranean basin.
    Mínguez Sabater A, Conde Amiel I, Ladrón Abia P, Martínez Delgado S, Camarasa Pérez Á, Berenguer M.
    Gastroenterol Hepatol; 2022 Mar 19; 45(3):177-185. PubMed ID: 34052401
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pediatric liver transplantation for primary sclerosing cholangitis.
    Miloh T, Anand R, Yin W, Vos M, Kerkar N, Alonso E, Studies of Pediatric Liver Transplantation Research Group.
    Liver Transpl; 2011 Aug 19; 17(8):925-33. PubMed ID: 21506253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Inflammatory bowel disease and liver transplantation for primary sclerosing cholangitis.
    van de Vrie W, de Man RA, van Buuren HR, Schouten WR, Tilanus HW, Metselaar HJ.
    Eur J Gastroenterol Hepatol; 2003 Jun 19; 15(6):657-63. PubMed ID: 12840678
    [Abstract] [Full Text] [Related]

  • 14. Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Fattahi MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, Bagheri Lankarani K, Taghavi AR, Ejtehadi F.
    Inflamm Bowel Dis; 2017 Jul 19; 23(7):1160-1167. PubMed ID: 28520586
    [Abstract] [Full Text] [Related]

  • 15. Liver transplantation for primary sclerosing cholangitis.
    Solano E, Khakhar A, Bloch M, Quan D, McAlister V, Ghent C, Wall W, Marotta P.
    Transplant Proc; 2003 Nov 19; 35(7):2431-4. PubMed ID: 14611979
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effectiveness and safety of anti-TNF therapy for inflammatory bowel disease in liver transplant recipients for primary sclerosing cholangitis: A nationwide case series.
    Altwegg R, Combes R, Laharie D, De Ledinghen V, Radenne S, Conti F, Chazouilleres O, Duvoux C, Dumortier J, Leroy V, Treton X, Durand F, Dharancy S, Nachury M, Goutorbe F, Lamblin G, Boivineau L, Peyrin-Biroulet L, Pageaux GP.
    Dig Liver Dis; 2018 Jul 19; 50(7):668-674. PubMed ID: 29655972
    [Abstract] [Full Text] [Related]

  • 18. Inflammatory bowel disease in primary sclerosing cholangitis: an analysis of patients undergoing liver transplantation.
    Miki C, Harrison JD, Gunson BK, Buckels JA, McMaster P, Mayer AD.
    Br J Surg; 1995 Aug 19; 82(8):1114-7. PubMed ID: 7648169
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Long-term outcomes of primary sclerosing cholangitis: an Australian non-transplant tertiary hospital perspective.
    Freeman E, Majeed A, Kemp W, Roberts SK.
    Intern Med J; 2019 Mar 19; 49(3):323-327. PubMed ID: 30043518
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.